AtriCure cryoICE cryo-ablation probe (CRYO2)— 510(k) K180138

Substantially Equivalent

AtriCure, Inc.

FDA 510(k) clearance K180138 for AtriCure cryoICE cryo-ablation probe (CRYO2), Substantially Equivalent on 2018-02-15. Applicant: AtriCure, Inc..

Clearance details

Applicant: AtriCure, Inc.
Product code: Code GXH
Advisory panel: Neurology
Date received: 2018-01-17
Decision date: 2018-02-15
Decision: Substantially Equivalent
Clearance type: Special
Location: Mason, OH, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.